Mutations of SQSTM1 occur in about 10% of patients with Paget's disease of bone (PDB), but it is unclear whether they play a causal role or regulate susceptibility to an environmental trigger. Here we show that mice with a proline to leucine mutation at codon 394 of mouse sqstm1 (P394L), equivalent to the P392L SQSTM1 mutation in humans, develop a bone disorder with remarkable similarity to PDB. The P394L mutant mice developed focal bone lesions with increasing age and by 12 months, 14/18 (77%) heterozygotes and 20/21 (95%) homozygotes had lesions, compared with 0/18 (0%) wild-type littermates (P < 0.001). Lesions predominantly affected the lower limbs in an asymmetric manner and were characterized by focal increases in bone turnover, with increased bone resorption and formation, disruption of the normal bone architecture and accumulation of woven bone. Osteoclasts within lesions were larger and more nucleated than normal and some contained nuclear inclusions similar to those observed in human PDB. Osteoclast precursors from P394L mutant mice had increased sensitivity to RANKL in vitro resulting in the generation of osteoclasts that were larger and more nucleated than those generated from wild-type littermates. There was increased expression of sqstm1, autophagy-related gene 5 (atg5) and light chain 3 gene (lc3) in osteoclast precursors and increased LC3-II protein levels in Bafilomycin-treated osteoclasts from P394L mutant mice compared with wild-type suggesting dysregulation of autophagy and enhanced autophagosome formation. These studies demonstrate that SQSTM1 mutations can cause a PDB-like skeletal disorder in the absence of an additional trigger and provide a new disease model for PDB.
INTRODUCTION
Paget's disease of bone (PDB) is a common condition with a strong genetic component characterized by focal increases in bone turnover, which can lead to various complications, including bone pain, deformity, pathological fractures and deafness (1) . Current evidence suggests that PDB is a polygenic disorder caused in part by protein-coding mutations affecting the SQSTM1 gene which cause a dominantly inherited form of the disease which is highly penetrant (2, 3) and by common variants at the CSF1, TNFRSF11A and OPTN loci which predispose to PDB in patients who do not carry SQSTM1 mutations (4) . Mutations affecting the Sequestosome 1 gene (SQSTM1) occur in between 20 and 50% of patients with a family history of PDB, and 5 and 20% of patients with 'sporadic' disease (1) . The SQSTM1 gene encodes p62, a scaffold protein that is involved in the regulation of nuclear factor kappa B (NFkB) signalling, osteoclast formation, autophagy and apoptosis (5) . Virtually, all of the PDB-associated mutations described so far lie within or are close to the ubiquitin-associated (UBA) domain of the gene product (2, 3, (6) (7) (8) (9) . Most of these mutations impair or abolish the ability of p62 to bind polyubiquitin chains, suggesting that this may be a unifying mechanism by which PDB occurs (10) . Previous studies have shown that SQSTM1 mutations activate NFkB signalling and enhance osteoclastogenesis in vitro (11) (12) (13) , but the molecular mechanisms by which this occurs are incompletely understood.
The penetrance of PDB in SQSTM1 mutation carriers increases with age to reach 80% by the seventh decade (6, 14, 15) . Recent reports have suggested that the onset of the disease is delayed in offspring of carriers (15) and this, coupled with a decreasing incidence of the disease in some countries over the past 25 years (16, 17) , has led to the suggestion that SQSTM1 mutations may not be sufficient to cause PDB and that an additional environmental trigger is required (18) . Experimental evidence has been presented to suggest that infection of osteoclast precursors early in life by measles or distemper virus might act as such a trigger (18) , but evidence for this is conflicting (1) . The aim of this study was to determine whether SQSTM1 mutations play a causal role in PDB by generating a mouse in which the proline residue at codon 394 of sqstm1 is replaced by leucine (P394L), which mimics the P392L mutation of SQSTM1, most commonly associated with PDB in humans (14) .
RESULTS

P394L mutant mice develop Pagetic-like skeletal lesions on microCT analysis
Mice carrying the P394L mutation were viable and fertile, and offspring of heterozygote mating displayed the expected Mendelian distribution of genotypes. We screened for the presence of bone lesions by performing microCT analysis focusing on the hind limbs and lumbar vertebrae. No lesions were observed in 4-month-old mice, but by 8 months, 1/4 (25%) heterozygous mice (P394L +/2 ) and 7/10 (70%) homozygous mice (P394L +/+ ) had developed focal osteolytic lesions mainly affecting the hind limbs compared with 0/8 (0%) wildtype littermates (P , 0.001). By 12 months of age, 14/18 (77%) P394L
+/2 and 20/21 (95%) P394L +/+ mice had developed lesions compared with 0/18 wild-type littermates (P , 0.001). The distribution and severity of lesions are summarized in Table 1 which illustrates that the number of lesions per mouse was greater in P394L +/+ mice when compared with P394L +/2 mice. There was no difference in the proportion of male and female mice with lesions or in the severity of lesions between genders (data not shown). Examples of lesions visualized by 3D microCT reconstruction are shown in Figure 1B -F. The most common sites affected were the distal femur and proximal tibia close to the growth plate ( Fig. 1B and C) . Larger lesions were found less commonly affecting the shaft of the long bones ( Fig. 1D and E) . Crosssectional analysis of the reconstructed lesions revealed disorganized bone structure within the trabecular compartment and osteolytic lesions within the cortex (Fig. 1F and G) . Most lesions comprised both osteolytic and osteosclerotic components. Affected bones also showed evidence of cortical thickening and bone expansion ( Fig. 1I and L) , but we did not observe bending deformity of the bones as sometimes occurs in advanced human PDB. The spine was affected much less often than the tibia and femur. We identified lumbar spine lesions in one out of eight P394L +/+ mutant mice (Fig. 1O ), but no lesions were observed in eight P394L +/2 mutant mice that we studied. In order to determine whether lesions might have developed as the result of somatic mutations, we conducted DNA sequencing of exon 8 of sqstm1 in bone lesions from three P394L +/2 mice and compared these results with unaffected tissue. No additional mutations of sqstm1 within the bone lesions were detected (data not shown).
Young P394L mice have normal trabecular bone density and structure
In order to establish whether the P394L mutation causes generalized abnormalities of bone mass and structure, we used microCT to examine the tibiae of 4-month-old animals, since at this point none of the mutant mice had developed focal lesions. Analysis of trabecular bone density and structure at the proximal tibial metaphysis of 4-month-old male mice revealed no significant differences in bone volume to total volume, trabecular thickness (Tb. Th), trabecular spacing (Tb. Sp) and trabecular number (Tb. N) between mutant mice and wild-type littermates (Supplementary Material, Table S1 ).
P394L mice exhibit focal abnormalities of bone turnover and osteoclast morphology
Histological analysis of bone lesions identified by microCT showed evidence of increased and disorganized bone turnover with disruption of normal trabecular and cortical architecture ( Fig. 2A) , increased numbers of osteoclasts ( Fig. 2E and F) increased bone formation as detected by calcein double labelling (Fig. 2B ) and woven bone as detected by polarized light microscopy ( Fig. 2C and D) . Bone histomorphometric analysis showed a significant increase in mineral apposition rate and mineralizing surface and a 10-fold increase in bone formation rate within the focal lesions when compared with unaffected bones (Table 2) . Resorption surface and osteoclast numbers within the bone lesions were also significantly increased when compared with unaffected bone ( Table 2) . Examination of three focal bone lesions by transmission electron microscopy revealed the presence of nuclear inclusions in 3 of 20 osteoclasts examined, similar to those that have been observed in human PDB (19, 20) (Fig. 2I and J) . The inclusions consisted of multiple microcylindrical structures, or filaments arranged in a paracrystalline array which individually were 12 nm in diameter. The dimensions are similar to that Osteoclast formation is increased in bone marrow macrophages from P394L mutant mice
Studies in vitro showed that M-CSF-and RANKL-induced osteoclast formation from bone marrow macrophages was significantly greater in P394L +/2 and P394L +/+ mice when compared with wild-type littermates ( Fig. 4A-C) . Moreover, osteoclast precursors from mutant mice showed evidence of increased sensitivity to RANKL when compared with wildtype cells as evidenced by the fact that osteoclast formation was observed at a RANKL concentration as low as 10 ng/ ml, compared with 50 ng/ml which was necessary to reproducibly induce osteoclast formation in wild-type cells (Fig. 4C) . The osteoclasts generated were larger and contained more nuclei than wild-type osteoclasts (Fig. 4D) . There was no difference in osteoclast formation rate or nuclearity between P394L +/2 and P394L +/+ mice. Bone resorption was significantly increased in osteoclast cultures generated from both P394L +/2 and P394L +/+ mice resulting in a 2 -3-fold increase in the total resorption area when compared with cultures prepared from wild-type mice (Fig. 4E) .
The P394L mutation affects autophagy in osteoclast lineage cells
We quantified levels of expression for sqstm1, the microtubule-associated protein 1 light chain 3 gene (lc3) and the autophagy-related gene 5 (atg5) using real-time PCR in M-CSF-dependent macrophages and osteoclast precursors derived from P394L +/+ mice and wild-type littermates. There was a significant increase in sqstm1, lc3 and atg5 expression in the P394L +/+ osteoclast precursors when compared with the wild-type controls; however, no significant differences in sqstm1, lc3 and atg5 expression were observed in P394L
+/+ and wild-type M-CSF-dependent macrophages ( Fig. 5A -C) .
Western blotting identified a significantly higher level of LC3-II in P394L
+/+ and P394L +/2 osteoclasts when compared with wild-type controls after treatment with Bafilomycin A, which inhibits autophagosome -lysosome fusion ( Fig. 5D and E). There was no significant difference in LC3-II levels observed in vehicle-treated P394L +/+ , P394L +/2 and wildtype osteoclasts (Fig. 5E) . Rapamycin, which induces autophagy through the inhibition of the mammalian target of rapamycin, was used as a positive control.
DISCUSSION
Here we have shown that mice that carry the P394L mutation of sqstm1 develop a skeletal disorder with remarkable similarity to PDB. Both P394L +/2 and P394L +/+ mutant mice developed mixed osteolytic and osteosclerotic bone lesions predominantly targeting the distal femur and proximal tibia with increasing age, mimicking the age-related increase in penetrance of PDB that is seen in humans (14, 15, 22) . As in human PDB, the bone lesions were asymmetrical and Osteoclasts from lesions of the P394L +/+ and P394L +/2 mice contained significantly more nuclei than osteoclasts from the WT mice (P , 0.0001 and P , 0.001, respectively). Osteoclasts from unaffected areas from P394L +/+ mice were not significantly different from wild-type (WT).
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Human Molecular Genetics, 2011, Vol. 20, No. 14 unaffected bone appeared normal as evidenced by the fact that at 4 months of age, before lesions had started to develop, microCT analysis showed no abnormalities in either P394L +/2 or P394L +/+ mutant mice. In keeping with this, bone histomorphometry was also normal in unaffected bone from P394L mutant mice, whereas histological analysis of bone lesions showed marked increases in bone resorption and bone formation with accumulation of woven bone. Osteoclasts were more numerous, larger and more multinucleated than normal, exactly as occurs in human PDB and some contained nuclear inclusions consisting of microcylindrical structures 12 nm in diameter that are very similar to those that have been observed in human PDB (19) (20) (21) .
The nuclear inclusions that have been observed in PDB were originally thought to represent paramyxovirus nucleocapsids (19) , but their true identity is unknown and we have previously reported that Pagetic inclusions differ morphologically from those found in subacute sclerosing panencephalitis (23); the archetypical slow virus disease caused by measles virus infection (24) . On the other hand, intracellular inclusions have long been recognized to be a feature of human neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease which are thought to be caused in part by defects in degradation of abnormal protein aggregates by the proteasome and autophagy (5, 25) . Indeed, over recent years, dysregulation of autophagy has been implicated in the pathogenesis of a wide range of diseases, including neurodegenerative disorders (26, 27) , cancer (5) and inflammatory bowel disease (28) . Autophagy is the process by which cytoplasmic protein aggregates and organelles are delivered to lysosomes for degradation (29) . The autophagy-related gene 5 (ATG5), the microtubule-associated light chain 3 (LC3) and p62 are all known to play important roles in autophagy (5, 30) . The p62 protein plays a central role in autophagy by using its UBA domain to target polyubiquitinated proteins to the autophagic machinery by binding LC3 which is localized to the autophagosomal membrane. This results in delivery of p62 itself to autophagosomes for lysosomal degradation (29) . The fact that we observed increased levels of mRNA for the sqstm1, atg5 and lc3 genes in osteoclast precursors from P394L +/+ mice suggests that the P394L +/+ mutation results in dysregulation of autophagy during osteoclast differentiation. Moreover, the significant elevation in LC3-II protein levels that we observed in P394L +/+ and P394L +/2 osteoclasts after Bafilomycin A treatment (which inhibits autophagosome -lysosome fusion) suggests that autophagosome formation may be increased as the result of this mutation, since LC3-II levels correlate with autophagosome number within the cell (30) . It is therefore tempting to speculate that the nuclear inclusions observed in human PDB and in the model described here may represent abnormal protein aggregates related to abnormalities of the autophagy system, but further studies will be required to investigate this hypothesis.
Although the skeletal phenotype in mice with the P394L mutation closely resembles PDB in many respects, we acknowledge that differences also exist. For example, the proportion of P394L +/2 mice that developed more than one lesion was 40%, whereas we recently found that 65% of patients with human PDB attending secondary referral centres in the UK have lesions at more that one site (31) . +/+ and P394L +/2 cultures contained significantly more nuclei than osteoclasts from the WT cultures (P , 0.01 and P , 0.001, respectively). (E) Osteoclast cultures derived from P394L mutant bone marrow show increased resorption pit formation in vitro. Symbols are means and bars are SD from three independent experiments (n ¼ 5 in each experiment).
* P , 0.05, * * P , 0.01 from WT cultures.
However, since we screened for evidence of lesions by performing microCT restricted to the spine and lower limbs, we may have underestimated the true extent of the disease. The fact that we observed an allele dose effect of the P394L mutation on disease severity and extent is consistent with previous reports that homozygotes or compound heterozygotes for SQSTM1 mutations generally have more severe and extensive disease than heterozygotes (22, 32) , although it should be noted that at least one patient homozygous for the P392L mutation had disease of similar severity to siblings who were heterozygous for the mutation (2) . Another difference between the model reported here and human PDB is the distribution of lesions, which mostly occurred in the lower limbs as opposed to the axial skeleton which is predominantly affected in human PDB. This suggests that differences in the local micro-environment exist in mice which favour the development of lesions at these sites. Notably, the distal femur and proximal tibia are sites for tendon insertions into bone raising the possibility that biomechanical factors may play a role in lesion development, and this is in keeping with anecdotal reports which suggest that repetitive mechanical loading of specific bones may predispose to the development of lesions in human PDB (33, 34) . It is also of interest to note that these bones are commonly targeted in experimental models of metastatic bone disease and here, local increases in bone turnover and the anatomic arrangement of blood vessels in the metaphysis have been suggested to be responsible for lesion targeting (35) . It is possible that one or both of these factors may have combined to give the pattern of lesion development that we observed in the present study, but further studies will be required to investigate this issue. Some researchers have reported that focal lesions in PDB 
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Human Molecular Genetics, 2011, Vol. 20, No. 14 may occur as the result of somatic mutations in SQSTM1 (36), but this was not confirmed in another study (37) . In the present study, we found no evidence to suggest that additional somatic mutations of sqstm1 had occurred in bone lesions from heterozygous mice indicating that the factors discussed above were most likely responsible for the localization of bone lesions to specific regions of the skeleton. While our study has shown that a point mutation in the UBA domain of sqstm1 is sufficient to cause a PDB-like disorder in mice, this does not exclude the possibility that environmental factors might also influence disease severity and extent of PDB. For example, epidemiological studies have shown that the incidence and severity of PDB has decreased in the UK and New Zealand over the past 25 years (16, 17) , although interestingly, similar changes have not been observed in Italy (38) . At present, the reason for this is incompletely understood but possibilities would include dilution of the gene pool in some localities by migrants from low prevalence areas or changes in environmental factors that influence disease severity and extent in some regions and not in others. The availability of P394L mutant mice will represent a valuable tool with which to investigate these possibilities in a rigorous fashion.
In this study, we observed that osteoclast formation and bone resorption were increased in RANKL and M-CSF stimulate bone marrow macrophages prepared from P394L mutant mice when compared with the wild-type which is in keeping with the results of previous studies which have shown that SQSTM1 plays a key role in regulating osteoclastogenesis. For example, Duran et al. (39) showed that targeted disruption of sqstm1 in mice-impaired osteoclastogenesis mediated by parathyroid hormone related protein, whereas over-expression of the P392L mutation in osteoclasts under the control of the tartrate-resistant acid phosphatase (TRAcP) promoter was found to cause a generalized increase in bone resorption and osteopenia (40) . Other studies have shown that expression of the P392L variant of SQSTM1 increases osteoclast formation and nuclearity and inhibits apoptosis in osteoclasts generated from umbilical cord-derived monocytes (13) . It is of interest that Hiruma et al. (41) also generated mice with the P394L mutation using an approach very similar to that described here, but found no evidence of PDB-like bone lesions. In the Hiruma et al. (41) study, however, analysis was limited to five lumbar vertebra and the authors did not employ microCT to screen for the presence of bone lesions as we did. It seems likely that the differences in approach to phenotyping may explain the differences observed. Although Hiruma et al. (41) did not report evidence of increased nuclearity of P394L mutant osteoclasts, the osteoclast precursors from mutant mice were hypersensitive to RANKL and showed increased bone resorption, which is in agreement with the findings reported here.
In summary, the observations reported here are important in demonstrating that SQSMT1 gene mutations play a causal role in the pathogenesis of PDB and provide, for the first time, an animal model of PDB. The P394L mutant mice will represent a valuable tool with which to dissect the molecular mechanisms by which SQSTM1 mutations cause PDB; to investigate the role of environmental triggers for the disease and to investigate the pathophysiological basis by which lesions target to specific regions of the skeleton.
MATERIALS AND METHODS
Generation of SQSTM1 P394L mutant mice
To generate a mouse model for PDB associated with the SQSTM1 P392L mutation, we employed gene targeting to generate a mouse in which the proline residue at codon 394 of the mouse Sequestosome protein was replaced by a leucine residue (P394L) (Supplementary Material, Fig. S1 ). In brief, the targeting construct was generated by polymerase chain reaction (PCR) and cloned into the pGEM-5Zf(+) vector. The P394L mutation was created by site-directed mutagenesis using the quick-change kit (Stratagene), and the same technique was used to insert a Spe1 site upstream of exon 8 to facilitate identification of the targeting event. The vector was further modified by cloning a polylinker into a BamHI site downstream of exon 7, and this was used to insert a LoxP -Neo -LoxP cassette into the vector for positive selection. A diphtheria toxin cassette was cloned into the 3 ′ flank for negative selection. The plasmid was linearized with Asc1, purified by phenol/chloroform extraction and ethanol precipitation and transfected into E14 129/Ola embryonic stem cells by electroporation according to the standard techniques. Geneticin (200 mg/ml) was added to the culture medium after 48 h and resistant colonies were identified. These clones were initially screened for integration of the targeting vector by PCR across the 5 ′ and 3 ′ arms using primers out with the targeted region and primers within the LoxP-Neo-LoxP cassette. Clones which were positive for the recombination event on the PCR screen were further screened for correct integration using southern blotting using Spe1-digested genomic DNA. Integration of the C to T point mutation within exon 8 which results in generation of the P394L mutation was confirmed by DNA sequencing of positive clones. Cells from the positive clones were injected into recipient blastocysts from pregnant C57BL/6 females. Male chimeras generated from this procedure were mated with wildtype C57BL/6 females and germline transmission of the mutation was confirmed by genotyping of the offspring. Females from this cross were then mated with CMV-Cre expressing 129/sv males and the offspring tested for excision of the neomycin cassette by southern blotting. Males which were heterozygous for the mutation were crossed with C56BL/6 females to generate a founder colony of mice in which the P394L mutation was carried on a mixed 129/sv and C57BL/6 background. The colony was maintained by breeding heterozygotes, and the wild-type, heterozygous and homozygous animals used in this study are littermates.
MicroCT analysis
The skin was removed and hind limbs were fixed in 4% formalin-buffered saline and stored in 70% ethanol. MicroCT analysis was performed using a Skyscan 1172 system. For assessment of bone morphometry, the left tibia of 4-month-old animals was dissected free of most soft tissue, and scanned at a resolution of 5 mm (60 kV, 150 mA, using a 0.5 mm aluminium filter). The reconstruction was performed using the Skyscan NRecon package. Trabecular bone parameters were measured using Skyscan CTAn software in a stack of 200 slices immediately distal from the growth Human Molecular Genetics, 2011, Vol. 20, No. 14 2741 plate as described (42) . To screen for the presence of lesions, the entire limbs were initially scanned at a resolution of 16.9 mm, but more detailed scans of bones with lesions were performed at a resolution of 5 mm. Lesions were assessed independently by two observers who were blinded to the genotype. Lesions were scored according to their extension as mild (score ¼ 1), moderate (score ¼ 2) or severe (score ¼ 3). All scores for each animal were added to give a total severity score per animal. The two assessors ′ scores were averaged to give the final score.
Bone histology
Animals received intraperitoneal injections of calcein 4 days and 1 day before being killed. The skin was removed and the hind limbs fixed for 24 h in 4% formalin-buffered saline and stored in 70% ethanol. The samples were embedded in methyl methacrylate and 5 mm sections were cut using a tungsten steel knife. Sections were stained for TRAcP to visualize osteoclasts and counterstained with haematoxylin. Calcein double labelling was visualized on a Zeiss Axioimager fluorescence microscope fitted with a QImaging Retiga 4000R digital camera. Histomorphometry was performed using software developed in-house based on the Aphelion Image Analysis toolkit (ADCIS, France).
Transmission electron microscopy
Pagetic-like lesions were identified by microCT in two 15-month-old P394L +/+ mice, dissected out, fixed in gluteraldehyde, decalcified and post-fixed with osmium tetroxide. The samples were embedded in Epon and sectioned. Sections were stained using lead citrate and uranyl acetate and examined using a Phillips transmission electron microscope. One section per lesion per mouse was examined and in total 20 osteoclasts were assessed for the presence of nuclear and cytoplasmic inclusions.
Osteoclast culture
Osteoclasts were generated by treatment of bone marrow macrophages with M-CSF and RANKL according to the standard methods as previously described (43) . Prior to cell lysis for western blotting, osteoclasts were treated with 100 nM Bafilomycin A, or 100 nM rapamycin (Sigma-Aldrich) for 4 h. In order to obtain osteoclast precursors for RNA extraction, M-CSF-dependent macrophages were treated with RANKL for up to 48 h.
Resorption assay
Cells were flushed out of the long bones of the mice, and the resulting bone marrow cell suspension was purified using Ficoll-hypaque density-gradient centrifugation. The resulting bone marrow mononuclear cells were washed and plated at 10 5 cells per well in 16-well BD Biocoat Osteologic hydroxyapatite-coated tissue culture plates (SIS Ltd, Nottingham, UK). The cells were cultured in aMEM supplemented with 10% fetal calf serum, antibiotics and 100 ng/ml RANKL and 25 ng/ml M-CSF (R&D systems, UK). The culture medium was replaced with fresh medium every 2 days, and the plates fixed and stained using von Kossa after 10 days of culture. The stained wells were imaged using a Zeiss Axioimager microscope fitted with a using QImaging Retiga 4000R digital camera, and the resorption area was measured using the Fiji distribution of ImageJ.
Quantitative real-time PCR
Osteoclast precursors were generated in bone marrow cultures stimulated with RANKL and M-CSF for 48 h, and the RNA isolated using the Sigma GenElute TM Mammalian Total RNA Kit. RNA was quantified using the Nanodrop 1000 Spectrophotometer (Thermo Scientific) and complementary DNA was generated using the SuperScript III Reverse Transcriptase kit (Invitrogen). Primers and probes (Supplementary Material, Table S2 ) were designed using the Ensembl Genome Browser and the Roche website (Roche; Burgess Hill, UK). Real-time PCR was performed on a CFD-3240 Chromo 4 TM Detector (M J Research) and quantified using the Opticon Monitor TM software version 3. Levels of gene expression were expressed as copy number per 2 mg of total RNA.
Western blotting
Proteins were separated by sodium dodecyl sulphate -polyacrylamide gel electrophoresis and electroblotted onto Hybond-P membranes. Membranes were blocked with 5% (w/v) non-fat milk in tris buffered saline with tween (TBST) (50 mM Tris, 150 mM NaCl, 0.1% [v/v] Tween-20) and probed with primary antibodies to LC3 (1:1000, MBL) and actin (1:1000, Sigma). After washing with TBST, membranes were incubated with appropriate horseradish peroxidiseconjugated secondary antibodies, washed and visualized using SuperSignalw West Dura Extended Duraton Substrate (Thermo Scientific) on the SynGene GeneGnome. Intensities of bands were quantified using SynGene Gene Tools software.
Statistical analyses
Statistical analyses were performed using Minitab version 12 or SPSS. For categorical variables, differences between genotype groups were determined by Chi-square test. For continuous variables, differences between genotype groups were determined by ANOVA or by the Kruskal -Wallis test followed by Dunn's post-test for data that were not normally distributed.
